Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Business Update

11 Feb 2022 07:00

RNS Number : 3637B
TP Group PLC
11 February 2022
 

This announcement contains inside information

TP Group plc

("TPG", "TP Group" or "the Company")

Business Update

At 31 December 2021, TP Group's net debt was £1.6 million, with £5.4m of cash, £7.0m of bank debt, and the Science Group loan undrawn. The year-end cash balance benefitted from approximately £1.0m of deferred payments, most of which are now paid. The Science Group standby facility has not to date been required.

In the update on 16 December 2021, the Board advised that exceptional costs would increase and the business would likely incur additional one-off costs in the 2021 financial year in relation to contract liabilities in Maritime and impairment of goodwill and intangibles.

· Exceptional costs have increased to £3.0m from the previously reported £2.1m due to further headcount restructuring, and fees associated with the HSBC and Science Group loans.

· In recent weeks, the Board has been working closely with operating management to review legacy contracts in the Maritime business and it is apparent that project governance has been inadequate. As a result, provisions related to onerous Maritime contracts are now anticipated of approximately £4.5 million. At the present time, it is unclear whether this will all be a charge in 2021 or may relate to prior periods.

· The TP Group strategy was set out in the announcement on 1 November 2021. The corporate processes in relation to the non-core operations are continuing with interested parties. However, the anticipated valuations are lower than the current book values which are primarily based on the acquisition cost. As a result, an impairment of goodwill and intangibles is anticipated. While this non-cash charge is still under review, and subject to audit, the Board currently anticipate a write-down of intangible assets of around £11 million in 2021.

With regard to 2022 planning, the Board is now well advanced. Taking the difficult decisions in relation to legacy Maritime contracts should provide a more robust platform for the future. We expect our consultancy business to continue to perform in line with management expectations as it did in 2021. Subject to resolution of the issues within Maritime, the Board anticipate an improvement in performance through growth and margin enhancement programmes in the Services businesses and the reduction in the central costs undertaken in 2021.

 

TP Group plc

Tel: 01753 285 810

Martyn Ratcliffe, Executive Chairman

Derren Stroud, Chief Financial Officer

 

 

 

www.tpgroup.uk.com

 

 

 

Cenkos Securities plc (Nomad & Broker)

Tel: 020 7397 8980

Stephen Keys / Mark Connelly / Callum Davidson

 

www.cenkos.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGPUBGPUPPPUU
Date   Source Headline
5th Apr 201212:33 pmRNSHolding(s) in Company
5th Apr 201212:31 pmRNSHolding(s) in Company
30th Mar 201211:04 amRNSResult of EGM
15th Mar 20127:00 amRNSAcquisition and Placing
12th Mar 20127:00 amRNSTechnology Update
13th Jan 20129:34 amRNSHolding(s) in Company
4th Jan 20127:00 amRNSNew Technology Centre and Website
28th Nov 20119:47 amRNSHolding(s) in Company
22nd Nov 201111:49 amRNSHolding(s) in Company
17th Oct 20117:00 amRNSDirectorate Change
10th Oct 20113:53 pmRNSHolding(s) in Company
10th Oct 20113:46 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSBusiness Update
11th Aug 20117:00 amRNSInterim Results
11th Jul 20117:00 amRNSNotice of Results
28th Jun 20112:26 pmRNSHolding(s) in Company
6th Jun 20117:00 amRNSAppointment of Managing Director
19th May 201112:20 pmRNSAGM Update
19th May 201111:23 amRNSBusiness Update
17th May 20117:00 amRNSTechnology Partnership signed with Saudi Aramco
18th Apr 20117:00 amRNSDirector/PDMR Shareholding
4th Apr 201110:32 amRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSDirector/PDMR Shareholding
29th Mar 20117:00 amRNSPreliminary Results
28th Mar 20117:00 amRNSMoU signed with new global industrial partner
28th Feb 20117:00 amRNSEuropean DGC Feasibility Study
10th Feb 20119:54 amRNSNorth America DGC Development Project Update
8th Feb 20117:00 amRNSAppointment of Non Executive Director
1st Feb 20117:00 amRNSPre-close Trading Statement
12th Jan 20117:00 amRNSDGC Update
17th Dec 201011:58 amRNSENI DGC Update
13th Dec 20104:53 pmRNSHolding(s) in Company
13th Dec 20103:03 pmRNSHolding(s) in Company
13th Dec 20103:00 pmRNSHolding(s) in Company
13th Dec 20102:56 pmRNSHolding(s) in Company
13th Dec 201011:39 amRNSHolding(s) in Company
7th Dec 201010:47 amRNSDirector/PDMR Shareholding
6th Dec 201012:41 pmRNSResults of General Meeting
25th Nov 20109:22 amRNSOperational Update
12th Nov 20105:12 pmRNSNotice of posting of prospectus
12th Nov 20107:00 amRNSPlacing and Open Offer
5th Nov 20102:45 pmRNSPress Speculation
25th Aug 20107:00 amRNSNew Development Agreement
12th Aug 20107:00 amRNSInterim Results
6th Aug 20107:00 amRNSNotification of Results and Change of Advisor
5th Jul 20107:00 amRNSAppointment of Chairman
30th Jun 20108:16 amRNSAnnual Financial Report
24th Jun 20101:12 pmRNSAGM Statement
4th May 20107:00 amRNSDirectors' Dealings
29th Apr 201011:19 amRNSDirectors Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.